Diaverum wins major tender to provide renal care services in South West England

Report this content

Diaverum, the Swedish-born, global renal care provider, is pleased to announce that it has been awarded a significant new contract to supply life-enhancing renal care in South West England.

The tender, which was submitted in September 2023, came through the Gloucestershire NHS Foundations Trust Tender for ‘The Provision of a Renal Dialysis Managed Service’. It encompasses the units of Cotswolds, Severn and Ward B, which are located in Gloucester NHS Hospital, as well as the Forest Unit in Cinderford. 

This announcement marks Diaverum’s further expansion into South West England, where it has established itself as a long-term provider of renal care services. With the addition of these units, more than 225 patients in the area will now have access to Diaverum’s world-class, life enhancing renal care, through its standardised, proprietary care delivery model, enabled by a continuously evolving digital infrastructure.  

The new contract has already commenced for all four units. It encompasses the provision of fully managed services, including nursing, consumables, some pharmaceuticals, equipment and facilities.  

Commenting on the news, Lisa Jordan, Managing Director for Diaverum UK, said: “This latest win is fantastic news for Diaverum and serves to underscore the growth trajectory we’re on in the UK. There were a number of our competitors involved in what was a highly competitive tender. Our bid – combining best-in-class care at the right pricing - was clearly a compelling and winning offer. Many thanks to everyone involved for this tremendous win.” 

With this news, Diaverum UK has expanded its presence to 38 clinics across the country, with more than 700 staff caring for over nearly 3,300 patients, making it one of the organisation’s most dynamic and significant areas for growth worldwide.  

Marianna Sofocleous
Global Communications & Editorial Manager
marianna.sofocleous@diaverum.com

About Diaverum

Diaverum is a Swedish-born, multinational healthcare organisation that provides life-enhancing renal care to patients with Chronic Kidney Disease (CKD), empowering them to live fulfilling lives. 

Our vision is to transform the industry through patient-centric digital innovations, delivering and broadening access to the highest quality of care.

Our focus is to provide renal care tailored to patients’ needs and choices, offering a portfolio of treatments ranging from preventive care, haemodialysis, peritoneal dialysis and home care, to coordination of patients’ comorbidities and holiday dialysis.

As a global leader and the largest independent renal service provider in Europe, we care for around 40,000 patients across 450 clinics in 24 countries globally. Diaverum employs around 13,000 people worldwide and is headquartered in Malmö, Sweden.

www.diaverum.com

Subscribe

Media

Media

Quotes

This latest win is fantastic news for Diaverum and serves to underscore the growth trajectory we’re on in the UK. There were a number of our competitors involved in what was a highly competitive tender. Our bid – combining best-in-class care at the right pricing - was clearly a compelling and winning offer. Many thanks to everyone involved for this tremendous win.
Lisa Jordan, Managing Director - Diaverum UK